Ulf Nehrbass

Chief Executive Officer at Luxembourg Institute of Health

Health Technology

Commercial Services

Profile

Ulf Nehrbass is currently the Chief Executive Officer at Luxembourg Institute of Health.
Previously, he held the same position at Qurient Co., Ltd.

Ulf Nehrbass active positions

Companies	Position	Start
Luxembourg Institute of Health Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.	Chief Executive Officer	-

All active positions of Ulf Nehrbass

Former positions of Ulf Nehrbass

Companies	Position	End
QURIENT CO., LTD.	Chief Executive Officer	-

See the detail of Ulf Nehrbass's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ulf Nehrbass's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
QURIENT CO., LTD.	Health Technology

Private companies	1
Luxembourg Institute of Health Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass.	Commercial Services